Anticorps Anti - eIF2Bbeta (N-terminal) produit en lapin, environ 1,0 mg / mL, anticorps isolé affinité, solution aqueuse tamponnée

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Anti-eIF2Bβ (N-terminal) antibody produced in rabbit is suitable for the following applications: Immunoprecipitation at a concentration of 3-5µg using K562 cell lysates Indirect immunofluorescence (at a concentration of 2-5µg/mL using paraformaldehyde-fixed NIH-3T3 cells over-expressing human eIF2Bβ) Western blotting at a concentration of 2-4µg/mL using K562 or AT3B1 cell lysatesYale Center for High Throughput Cell Biology IF-tested antibodies. Each antibody is tested by immunofluorescence against HUVEC cells using the Yale HTCB IF protocol. To learn more about us and Yale Center for High Throughput Cell Biology partnership, visit sigma.com/htcb-if

Biochem/physiol Actions

Recent studies have linked inherited mutations in any of the five eIF2B subunits to a fatal human disorder known as childhood ataxia with central nervous system hypomyelination (CACH) or vanishing white matter (VWN) disease. The eIF2B -α, -β and - δ subunits downregulate eIF2B activity in response to the phosphorylation of eIF2 on Ser51.

Translation initiation factor eIF-2B subunit β is a protein encoded by EIF2B2 gene in humans. It is a five-subunit complex that catalyzes guanine nucleotide exchange on eIF2. It is associated with the cause of autosomal recessive disorders. Autosomal recessive inherited mutations in each of the five eukaryotic initiation factor 2B (eIF2B) subunits are known to cause white matter abnormalities called eIF2B-related disorders.

Disclaimer

Unless otherwise stated in our catalog, our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

General description

Translation initiation factor eIF-2B subunit beta eIF2B β is a component of the regulatory subcomplex of eIF2B along with the eIF2Bα and -δ subunits. eIF2Bβ gene is mapped to human chromosome 14q24.3.

Physical form

Solution in 0.01 M phosphate buffered saline, pH 7.4, containing 15 mM sodium azide.

Specificity

Anti-eIF2BNβ-terminal) specifically recognizes human, mouse, and rat eIF2Bβ.

Storage and Stability

For continuous use, store at 2–8 °C for up to one month. For extended storage, freeze in working aliquots. Repeated freezing and thawing, or storage in “frost-free” freezers, is not recommended. If slight turbidity occurs upon prolonged storage, clarify the solution by centrifugation before use. Working dilutions should be discarded if not used within 12 hours.